Smart scans may boost power of radioactive seeds against cancer
NCT ID NCT07327515
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using PET/CT scans to guide radioactive seed placement can better target and kill tumors in people with solid cancers. About 90 adults will be assigned to one of three planning methods: standard CT, PET/CT with standard dose, or PET/CT with a biologically optimized dose. The goal is to see if the PET/CT-guided approaches improve tumor control and survival without increasing side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The 960th Hospital of People's Liberation Army (PLA)
Jinan, Shandong, 250031, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to shrink Hard-to-Treat tumors
- Cancer gene study aims to unlock prognosis secrets
- Massive 10-Year health check: what happens when chronic diseases collide?
- X-rays may damage red blood cells: study seeks safe limits
- New scan could sharpen cancer detection
- Radiation and immunotherapy join forces in new cancer trial